Since Marker Therapeutics was founded in 2015, it has participated in 12 rounds of funding. In total Marker Therapeutics has raised $98.0M. Marker Therapeutics' last funding round was on Dec 2024 for a total of $9.5M.
Marker Therapeutics has 4 investors, including Cancer Prevention & Research Institute of Texas, National Institutes of Health and Small Business Innovation Research. The latest investment occurred in Dec 2024.